Targeted Immunotherapy to Revolutionize Cancer Treatment with Carl June, MD -- Overthrowing the Emperor of all Maladies: Moving Forward Against Cancer Series -- Exploring Ethics

6/9/2014; 47 minutes

Dr. Carl June presents a revolutionary form of targeted immunotherapy to fight cancer, a treatment that involves genetically modifying the patient's own T lymphocytes (a type of white blood cell) to attack cancer cells. Dr. June's team was the first to use these engineered T cells to treat Emily Whitehead, a six-year-old girl with acute leukemia, and now, two years later, she remains cancer-free. Similar results with other patients confirm that this type of T cell therapy is one of the most exciting new approaches to treating cancer, stimulating the biotechnology and pharma industries to develop the means to deliver this therapy to patients. Dr. June was presented by the Center for Ethics in Science and Technology in San Diego. Recorded on 05/14/2014. (#25970)

Links & Resources

More Programs With

 

SIGN UP FOR EMAIL UPDATES
Subscribe to receive email notifications about featured videos.
(c)2019 Regents of the University of California. All right reserved. Terms and Conditions of Use.